@requesto6d

In 2024, Eli Lilly called out misuse of its weight loss meds like Mounjaro without obesity diagnoses at the Oscars. Fast forward to 2025, and they're now targeting non-FDA-approved competitors.

0 reply

0 recast

0 reaction